NFE2L2 and metabolic disease: Metabolic disorders are accompanied by inflammation, which inhibits kelch-like-enoyl-CoA hydratase associated protein-1 (Keap-1), leading to a decrease in the nuclear factor erythroid-2 related factor-2 (Nrf2) and increased nuclear factor kappa-B (NF-ĸB)1.